Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
17 November 2017 09:18
It's estimated 8,000 women could benefit from the drugs
Women diagnosed with untreatable breast cancer are being given fresh hope, with the approval of two new "breakthrough" medicines for widespread use across England's health service.
The National Institute for Health and Care Excellence (Nice) has approved NHS use of palbociclib and ribociclib - drugs that are shown to slow down advance cancer and delay the need for chemotherapy.
Nice - which has rejected palbociclib in the past because of its high cost - has announced the new agreement after negotiating a new lower price with manufactured Pfizer.
A life-changing breakthrough
Around 45,000 women receive new diagnoses of breast cancer each year in England, and it's estimated 8,000 women could benefit from the ground-breaking treatment.
Nicholas Turner, trial lead and professor of molecular oncology at the Institute of Cancer Research (ICR) in London and consultant medical oncologist at the Royal Marsden, says: "The development of this brand new class of cancer drug is one of the most important breakthroughs for women with advanced breast cancer in the last two decades.
"In clinical trials, palbociclib and ribociclib have made a huge difference to women's lives - slowing down tumour growth for nearly a year, and delaying the need for chemotherapy with all its potentially debilitating side-effects. These drugs have allowed women to live a normal life for longer."
Treatment for women of any age
Women who are pre-menopausal and have been diagnosed with oestrogen receptor positive breast cancer after it the disease has spread will be eligible for palbociclib.
Post-menopausal women diagnosed who are diagnosed under the same conditions will be treated with ribociclib, manufactured by Novartis.
Both drugs work in a similar way, and are shown to hold back breast cancer for at least 10 months, affording women a normal life for longer.
Even if your cancer has spread, if you have had chemotherapy in the last three months, are taking strong painkillers or have a terminal prognosis, we may still be able to cover you for holidays and overseas travel with our specialist cancer travel insurance.
15 December 2018
Older people are 50% more likely to take themselves to A&E if they live alone, a new study has revealed.
[more...]
14 December 2018
Over 4.3 million older people in the UK are at risk of not getting the care they need just because of their postcode, new research has revealed.
13 December 2018
Space tourism could move one giant leap closer this week as Virgin Galactic expects to reach "space altitudes" for the first time.
12 December 2018
If you're worried about piling on the pounds this Christmas, regular home weighing could prevent you from excessive festive eating and drinking.
11 December 2018
Airlines that automatically cancel return flights when passengers fail to show for their outbound journeys are being warned they risk breaking consumer law.
08 December 2018
Providing better conditions for disabled passengers is one of the main aims of a proposed new charter for airlines and airports.
07 December 2018
Women who don't attend cervical screenings should be offered testing kits they can use at home, new research suggests.
06 December 2018
Ryanair could be slapped with enforcement action from the airline regulator after it refused compensation for passengers hit by flight disruption caused by staff taking strike action.
05 December 2018
Protein supplements and muscle training could be the most effective ways to delay or reverse the effects of frailty, a new study suggests.
04 December 2018
Mumford and Sons bassist Ted Dwane has helped create a new exhibition to raise awareness of the loneliness felt by people living with multiple sclerosis (MS).
01 December 2018
A leading charity has praised the actions of Lloyd Russell-Moyle, saying the Labour MP had "done everybody a service" by disclosing his HIV status.
30 November 2018
Sweating out the daily stresses in a sauna could be linked to a reduced risk of death from cardiovascular diseases (CVD) in people aged 50 and over, according to a new study.